Tenascin in salivary gland tumours
- PMID: 1384222
- DOI: 10.1007/BF01611178
Tenascin in salivary gland tumours
Abstract
The distribution of tenascin immunoreactivity was analysed in salivary gland tissue and in various benign and malignant tumours of the salivary gland. In the non-neoplastic tissue, tenascin was seen in the areas of basement membranes of the ductal epithelium. No immunoreactivity could be observed in the serous or mucous glands. In pleomorphic adenomas, tenascin immunoreactivity could be seen in the stromal compartment. It was more pronounced in the dense stromal areas and chondroid elements than in the myxoid area. In Warthin's tumours, strong tenascin immunoreactivity could be observed in the basement membrane zone of the epithelial component. In the lymphatic component, faint reticular staining could be seen. In adenoid cystic carcinomas, acinic cell tumours and mucoepidermoid carcinomas, tenascin showed a linear stromal distribution. No intracytoplasmic immunoreactivity could be seen in any of the cases. The widespread tenascin positivity in salivary gland tumours suggests that tenascin may play a role in the induction and progression of salivary gland tumours, presumably by interfering with the normal parenchymal-mesenchymal interaction.
Similar articles
-
Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.Eur J Cancer B Oral Oncol. 1994 Nov;30B(6):393-9. doi: 10.1016/0964-1955(94)90018-3. Eur J Cancer B Oral Oncol. 1994. PMID: 7536507
-
Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.Pathol Res Pract. 1993 Mar;189(2):138-43. doi: 10.1016/S0344-0338(11)80083-X. Pathol Res Pract. 1993. PMID: 7686669
-
Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.J Laryngol Otol. 2006 Apr;120(4):298-304. doi: 10.1017/S0022215106000351. J Laryngol Otol. 2006. PMID: 16623973
-
Evaluation of the nucleolar organizer region associated proteins in minor salivary gland tumors.J Oral Pathol Med. 1991 Jul;20(6):291-5. doi: 10.1111/j.1600-0714.1991.tb00930.x. J Oral Pathol Med. 1991. PMID: 1716320 Review.
-
A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation.Biomed Res Int. 2018 Aug 1;2018:2897827. doi: 10.1155/2018/2897827. eCollection 2018. Biomed Res Int. 2018. PMID: 30155477 Free PMC article. Review.
Cited by
-
Tenascin immunoreactivity in normal and pathological bone marrow.J Clin Pathol. 1993 Mar;46(3):218-21. doi: 10.1136/jcp.46.3.218. J Clin Pathol. 1993. PMID: 7681854 Free PMC article.
-
Clinical and immunohistochemical analyses of parotid gland tumors.Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S20-2. doi: 10.1007/BF02439714. Eur Arch Otorhinolaryngol. 1997. PMID: 9065618
-
Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.J Clin Pathol. 2004 Nov;57(11):1151-5. doi: 10.1136/jcp.2003.015818. J Clin Pathol. 2004. PMID: 15509674 Free PMC article.
-
Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.Front Oral Health. 2023 Apr 17;4:942604. doi: 10.3389/froh.2023.942604. eCollection 2023. Front Oral Health. 2023. PMID: 37138857 Free PMC article. Review.
-
Tenascin and fibronectin in pleomorphic adenoma of the salivary gland.J Appl Oral Sci. 2006 Jun;14(3):198-202. doi: 10.1590/s1678-77572006000300010. J Appl Oral Sci. 2006. PMID: 19089073 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical